[1] Montaner J,Chacon P,Krupinski J,et al.Simvastatin in the acutephase of ischemic stroke:a safety and efficacy pilot trial[J].EurJ Neurol,2008,15(1):82-90.
[2]
[2] Lakhan S E,Bagchi S,Hofer M.Statins and clinical outcome ofacute ischemic stroke:a systematic review[J].Int Arch Med,2010,3:22.
[3] Alvarez-Sabin J,Huertas R,Quintana M,et al.Prior statin usemay be associated with improved stroke outcome after tissueplasminogen activator[J].Stroke,2007,38(3):1076-1078.
[5]
[4] Uyttenboogaart M,Koch MW,Koopman K,et al.Lipid profile,statin use,and outcome after intravenous thrombolysis for acuteischaemic stroke[J].J Neurol,2008,255(6):875-880.
[7]
[5] Meier N,Nedeltchev K,Brekenfeld C,et al.Prior statin use,intracranial hemorrhage,and outcome after intra-arterialthrombolysis for acute ischemic stroke[J].Stroke,2009,40(5):1729-1737.
[9]
[6] Prinz V,Endres M.The acute(cerebro)vascular effects of statins[J].Anesth Analg,2009,109(2):572-584.
[11]
[7] Bourcier T,Libby P.HMG CoA reductase inhibitors reduceplasminogen activator inhibitor-1 expression by human vascularsmooth muscle and endothelial cells[J].Arterioscler ThrombVasc Biol,2000,20(2):556-562.
[13]
[8] Notarbartolo A,Davi G,Averna M,et al.Inhibition of thromboxanebiosynthesis and platelet function by simvastatin in type IIahypercholesterolemia[J].Arterioscler Thromb Vasc Biol,1995,15(2):247-251.
[15]
[9] Sanguigni V,Pignatelli P,Lenti L,et al.Short-term treatment withatorvastatin reduces platelet CD40 ligand and thrombin generationin hypercholesterolemic patients[J].Circulation,2005,111(4):412-419.
[17]
[10] Zhang L,Zhang ZG,Ding GL,et al.Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant humantissue-type plasminogen activator in the rat[J].Circulation,2005,112(22):3486-3494.